Company page

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. is a public company traded under the ticker LRMR in the American market. The company has a market capitalization of approximately $415.5 million. Larimar focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.